- Basic researchers benefit from mechanistic insight in preserved living human tissue with data that aligns to NIH’s New Approach Methodology evaluation criteria on reproducibility and translatability.
- Translational teams get functional cytokine response data with strong concordance to clinical outcomes — anchored in intact human biology.
- Early drug developers get earlier, more confident go/no-go decisions from human-relevant data — before clinical trial investment.
National Advisory Group
MBBD, MD
Medical Oncologist
Breast Cancer
Mayo Clinic
MD, PhD
Medical Oncologist
Kidney Cancer
Yale School of Medicine
Director
UW Health | Carbone Cancer Center
Professor of Microscopy, Medical Imaging & AI
The University of Wisconsin-Madison
MD, MSc
Pathologist
Melanoma
Johns Hopkins Medicine